These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1246 related items for PubMed ID: 26318836

  • 1. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C, McAllister P, Walker H, Brashear A, Edgley S, Deltombe T, Khatkova S, Banach M, Gul F, Vilain C, Picaut P, Grandoulier AS, Gracies JM, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.
    Gracies JM, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, Khatkova S, Benetin J, Vecchio M, McAllister P, Ilkowski J, Ochudlo S, Catus F, Grandoulier AS, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Lower Limb Spasticity Study Group.
    Neurology; 2017 Nov 28; 89(22):2245-2253. PubMed ID: 29093068
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU.
    J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
    McAllister PJ, Khatkova SE, Faux SG, Picaut P, Raymond R, Gracies JM.
    J Rehabil Med; 2019 Oct 29; 51(10):813-816. PubMed ID: 31529136
    [Abstract] [Full Text] [Related]

  • 11. Composite active range of motion (CXA) and relationship with active function in upper and lower limb spastic paresis.
    Bayle N, Maisonobe P, Raymond R, Balcaitiene J, Gracies JM.
    Clin Rehabil; 2020 Jun 29; 34(6):803-811. PubMed ID: 32336148
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.
    Eur J Neurol; 2001 Nov 29; 8(6):559-65. PubMed ID: 11784339
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, Takahashi K.
    Toxins (Basel); 2020 Feb 18; 12(2):. PubMed ID: 32085529
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A, BoNT/TZD Study Team.
    J Neurol Neurosurg Psychiatry; 2009 Apr 18; 80(4):380-5. PubMed ID: 18977811
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y, Wu T, Hu X, Wang T.
    Eur J Phys Rehabil Med; 2017 Apr 18; 53(2):256-267. PubMed ID: 27834471
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug 18; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.